Valuation: Repligen Corporation

Market Cap 7.45B 6.54B 6.08B 5.58B 10.49B 717B 10.65B 72.23B 28.22B 353B 27.96B 27.35B 1,219B P/E 2026 *
121x
P/E 2027 * 73.2x
Enterprise Value 7.19B 6.32B 5.88B 5.39B 10.13B 693B 10.29B 69.77B 27.26B 341B 27B 26.42B 1,177B EV / Sales 2026 *
8.76x
EV / Sales 2027 * 7.43x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week-9.30%
Current month-3.28%
1 month-3.68%
3 months+11.56%
6 months-19.35%
Current year-19.47%
1 week 129
Extreme 129
148.37
1 month 129
Extreme 129
150.9
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
7/16/26 A Sell

Chief Financial Officer

-530 0.0009%
6/25/26 A Sell

Chief Financial Officer

-733 0.0013%
5/14/26 A Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%-9.30%+10.29%-22.82% 7.45B
+2.15%+3.50%-16.72%-6.60% 180B
+1.93%+2.09%-7.55%-3.93% 107B
+0.66%+2.59%+8.97%+66.48% 60.29B
+0.67%-2.85%+26.76%+55.55% 50.19B
+1.90%+3.57%-12.54%-43.58% 43.08B
+3.94%+3.41% - - 32.77B
+3.15%-1.58%-16.79%-42.41% 27.61B
+1.86%-4.96%+29.91%-5.65% 23.1B
+2.53%+2.47%-2.99%-4.36% 20.86B
Average +1.90%-3.05%+2.15%-0.81% 55.14B
Weighted average by Cap. +1.90%-0.53%-4.28%+3.38%

Financials

2026 *2027 *
Net sales 821M 721M 671M 615M 1.16B 79.07B 1.17B 7.96B 3.11B 38.87B 3.08B 3.02B 134B 944M 829M 771M 708M 1.33B 90.93B 1.35B 9.16B 3.58B 44.7B 3.54B 3.47B 155B
Net income 60.98M 53.56M 49.81M 45.7M 85.87M 5.87B 87.2M 591M 231M 2.89B 229M 224M 9.98B 101M 88.81M 82.59M 75.79M 142M 9.74B 145M 981M 383M 4.79B 380M 371M 16.55B
Net Debt -254M -223M -208M -191M -358M -24.5B -364M -2.47B -964M -12.04B -955M -934M -41.64B -432M -379M -352M -323M -608M -41.55B -617M -4.19B -1.64B -20.43B -1.62B -1.58B -70.64B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
27/07/26 $131.93 -0.02% 202,810
24/07/26 $131.96 -4.10% 1,359,904
23/07/26 $137.60 -1.78% 2,793,139
22/07/26 $140.09 +2.26% 2,685,528
21/07/26 $136.99 -5.84% 2,144,924
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
131.96USD
Average target price
178.05USD
Spread / Average Target
+34.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock